Related Experiment Videos
[Lyell syndrome and antibiotic therapy].
S Grifoni1, F Daviddi, S Gialloni
1Unità Ospedaliera Accettazione e Pronto Soccorso, Dipartimento di Emergenza, Accettazione, Azienda Ospedaliera Careggi, Firenze.
Recenti Progressi in Medicina
|June 5, 2001
Summary
Lyell syndrome, a severe drug reaction, presents diagnostic challenges and lacks effective treatments. Early diagnosis via skin biopsy is crucial for managing this high-mortality condition.
Area of Science:
- Dermatology
- Toxicology
Background:
- Lyell syndrome (LS) is a severe, idiosyncratic drug reaction with high mortality.
- Diagnosis is often delayed due to its complex presentation and lack of proven treatments.
Observation:
- A case of LS is presented in a patient treated with antibiotics, exhibiting an exantema-like eruption.
- Warning signs include diffuse erythema, fever, large bullae, and epidermal detachment leading to erosions.
Findings:
- Skin biopsy is essential for accurate LS diagnosis.
- Histologic findings of epidermal necrosis and basal cell degeneration, alongside negative immunostaining and Tzank tests, confirm LS.
- Aggressive treatment in this case yielded suboptimal results, potentially due to disease stage.
Implications:
- Highlights the critical role of early diagnosis through skin biopsy in managing Lyell syndrome.
- Underscores the need for improved therapeutic strategies for this severe cutaneous adverse drug reaction.
- Emphasizes the diagnostic utility of specific histological findings and negative immunodiagnostic tests in LS.